EMAIL THIS PAGE TO A FRIEND

Bioorganic & medicinal chemistry letters

Optimization of a privileged structure leading to potent and selective human melanocortin subtype-4 receptor ligands.


PMID 16364639

Abstract

Design and synthesis of potent MC4 selective agonists based on cyclohexylpiperidine derived cyclic urea, oxazolidinones, and sulfonamide based privileged structures are disclosed.